Mark J. Alles, See Remarks at CELGENE CORP /DE/ (CELG), sold 130,765 shares at $120.68 ($15.8M) on 2015-02-06, disclosed to the SEC on 2015-02-10.
Scheduled sale ($15.8M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $118.75 | 13,666 | $1.6M | 10.3% |
| 2 | $120.68 | 117,099 | $14.1M | 89.7% |
| Total | $120.48 avg | 130,765 | $15.8M | 100% |
| Filing → |
| SYRS | BUY | 2020-05-13 | $89K | — | Filing → |
| CELG | BUY | 2018-05-17 | $200K | — | Filing → |
| CELG | BUY | 2018-02-08 | $300K | — | Filing → |